top of page



Leading the way with innovative technology, launching a new era of wound repair in Australia

Mr. Stewart Hemsley
Chief Executive Officer

Stewart has been self-employed across a number of industry sectors for most of his working life and a few years ago established what is today, Surgical BioFix Ltd.  He has a long history of involvement in health and education related facilities having served in an honorary capacity on a number of boards of management and advisory committees in those disciplines, as well as commercial involvement in property development.


He has been responsible for the design and construction of the Surgical BioFix Ltd facility in Brisbane after having negotiated the IP Licence Agreement regarding the production and distribution of the Surgical BioFix Ltd produced human tissue allograft products into the Australia, New Zealand and South Pacific markets.


He was also responsible for the sourcing and training of staff for the facility.  Stewart has many years of experience in commercial and community group liaison with local, state and federal government and is a Justice of the Peace in Queensland and New South Wales.


A/Prof. Tony Parker, PhD
Chief Scientific Officer

Associate Professor Tony Parker has over 15 years of experience in tissue injury, wounds and tissue engineering research. Tony has a PhD in cell & molecular biology from Queensland University of Technology (QUT) and maintains leadership positions within the School of Biomedical Sciences at QUT where he teaches anatomy, physiology, cell and molecular biology and wound science.


Tony leads the Tissue Repair and Translational Physiology (TRTP) Group in the Centre for Biomedical Technologies (CBT) at QUT. His research team focuses on the biochemical implications of musculoskeletal and skin tissue injury and recovery processes and human stress responses. In particular, his team specialises in the biochemical characterisation of wound and tissue fluids in order to understand the underlying biological processes of injury and recovery and for the development of future diagnostics. He has published 46 peer reviewed journal articles in the international scientific literature in areas including wound and tissue injury and has trained over 29 research and higher degree students.

Tony provides advice on the scientific approaches to production and quality processes at Surgical BioFix. He also helps liase with clinicians and academics to support clinical research engagement activities of the company.



Dr. Kylie Alcorn, MBBS, FRACP

Medical Director

Dr Kylie Alcorn is an Infectious Disease physician working in South East Queensland Hospitals. Her professional interests include general Infectious Disease, orthopaedic infections and the professional development of doctors. She has held positions including Acting Director of Infectious Disease and Immunology and served on several medical advisory committees in several hospitals in South East Queensland.

After completing undergraduate studies at the Queensland University of Technology (QUT), she completed her medical degree training at the University of Melbourne before returning to the glorious warm weather in Brisbane. She completed her Fellowship in Medicine with specialty training in Infectious Diseases in South East Queensland, and postgraduate observerships in Berlin and Oxford.

She is an active researcher with current projects investigating vaccine development for malaria and antibiotics for diabetic foot infections. Dr Alcorn is committed to life-long learning and is soon to complete a Masters in Tropical Medicine and Public Health from James Cook University.

Dr. Platon Choptiany
Medical Director Designee

Dr Choptiany is originally from Winnipeg, Manitoba, Canada but moved to Brisbane in 2006 where he completed his MBBS at the University of Queensland.  Following this he completed his Fellowship in General and Acute Care Medicine and is currently undertaking Advanced Training in Infectious Diseases. 


He has worked throughout Queensland over the last 10 years including Gold Coast, Rockhampton, Caboolture, Murgon, Cherbourg and Brisbane. 


He is currently undertaking a Masters of Public Health through the University of Queensland and has previously completed a Bachelor of Science and Masters of Science in Physiology at the University of Manitoba. 


Dr. Raju Tippana
Quality Manager

Dr. Raju Tippana is an accomplished Quality professional and bioanalytical scientist with over 12 years of experience across research and development, code of Good Manufacturing Practice (cGMP), manufacturing, quality control, and regulatory compliance in the pharmaceutical and biopharmaceutical industries. He has made significant contributions to Quality Control in cGMP manufacturing of recombinant proteins and vaccines, including the development of bioanalytical methods, validations, and stability programs in accordance with regulatory guidelines.


Raju earned his PhD as part of the Tissue Repair and Regeneration group at the QUT. His doctoral research focused on designing and developing novel tissue-targeted recombinant chimeric fusion proteins to stimulate the wound healing process, particularly in peripheral nerve tissue regeneration.

As our Quality Manager, Raju ensures that the Surgical Biofix activities and products are compliant with the regulatory requirements of the code of Good Manufacturing Practice and the Therapeutic Goods Administration (TGA). In doing so, he rigorously maintains the quality, reproducibility and safety of our product, and champions the continuous improvement of our quality management system to ensure Surgical Biofix remains agile and efficient.

Want more information?

bottom of page